Ligand Pharmaceuticals | LGND - Stock


Ligand Pharmaceuticals reported $11.9M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Amgen USD 6.22B 121M Dec/2025
Anika Therapeutics USD 16.28M 638K Sep/2025
Arrowhead Research USD -173.08M 173.08M Dec/2024
Baxter International USD 2.23B 228M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Enviri Corporation USD 195.42M 360K Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 132.07M 11.1M Dec/2025
Intrexon USD 287K 68K Dec/2022
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
Karyopharm Therapeutics USD 3.97M 1.03M Sep/2025
Ligand Pharmaceuticals USD 11.9M 3.59M Sep/2025
MacroGenics USD 8.75M 530K Sep/2025
Merck USD 6.44B 157M Sep/2025
Pacira USD 157.68M 9.52M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Rigel Pharmaceuticals USD 13.3M 2.88M Sep/2025
Veracyte USD 20.55M 219K Dec/2025